Niki BioSolutions, Inc. (NIKI) Current Deferred Revenue (2018 - 2025)

Niki BioSolutions' (NIKI) quarterly Current Deferred Revenue came in at $43982.0 in Q2 2025, down 20.73% on a QoQ basis from $55484.0 in Q4 2019.

Niki BioSolutions, Inc. (NIKI) Current Deferred Revenue (2018 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 3 years of Current Deferred Revenue data on file, last reported at $43982.0 in Q2 2025.

Quarterly Current Deferred Revenue changed N/A year-over-year to $43982.0 in Q2 2025, while the trailing twelve-month figure through May 2025 was $43982.0 (changed N/A YoY) and the FY2025 annual result came in at $43982.0, changed N/A from the prior year.
Current Deferred Revenue declined to $43982.0 in Q2 2025, from $55484.0 in the prior quarter.
In the past five years, Current Deferred Revenue ranged from a high of $43982.0 in Q2 2025 to a low of $43982.0 in Q2 2025.

Download Data